Walmart Reaches $50 Million Opioid Settlement

Walmart agreed to a $50 million settlement with the Justice Department and the Drug Enforcement Administration over claims its pharmacies illegally filled thousands of invalid opioid prescriptions and helped fuel the national opioid epidemic. The government said Walmart knew since 2013 that some prescribers were operating as “pill mills,” with compliance staff aware of the conduct even as reports were filed, and pharmacists flagged concerns via thousands of refusal-to-fill forms. A compliance director reportedly advised the team to prioritize sales and patient awareness over addressing the reports. The settlement includes a memorandum of agreement with the DEA to monitor dispensing, report suspected illegal prescribing, and bolster procedures to prevent future violations. Had Walmart been found liable, penalties could have run into billions based on per-prescription and per-suspicious-order fines, highlighting the DOJ’s most significant civil action against a retailer in the opioid crisis. Coverage notes that terms beyond the $50 million were not fully disclosed and that Walmart had prior settlements related to the crisis.